News Daily News Weight Regained Within 18 Months of Stopping GLP-1 Drugs Michael O'Riordan January 08, 2026
News Daily News Thrombolysis May Be OK for DOAC-Treated Patients With Ischemic Stroke Todd Neale January 07, 2026
News Daily News SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide Michael O'Riordan December 18, 2025
News Daily News Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis Yael L. Maxwell October 24, 2025
News Daily News Bax24: Baxdrostat Successful Again, This Time in Resistant Hypertension Todd Neale October 07, 2025
News Daily News ACC: It’s Time for Clinicians to Address Inflammation in CVD Caitlin E. Cox October 03, 2025
News Daily News Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s Michael O'Riordan September 18, 2025
News Daily News Half of Patients Stop Semaglutide for Weight Loss by 1 Year Todd Neale September 18, 2025
News Daily News AI-Supported Coaching Shows Promise for Improving Glycemic Control L.A. McKeown August 25, 2025
News Daily News Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol Michael O'Riordan August 06, 2025
News Daily News Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC Michael O'Riordan June 25, 2025
News Daily News Weight-Loss Drug MariTide Gains Momentum in Phase II Trial Caitlin E. Cox June 25, 2025
News Daily News GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease L.A. McKeown June 12, 2025
News Daily News Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says Todd Neale June 06, 2025